The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Wegovy-maker Novo Nordisk said on Thursday it had told all its staff to return to the office as the drugmaker's new CEO tries ...

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

CNBC's Michael Santoli and Melissa Lee discuss pharmaceutical company Novo Nordisk cutting jobs. Michael Douglas says 11-year ...

Novo Nordisk will soon require its staff to work in the office full-time after it cut thousands of jobs. The Ozempic maker ...

Novo Nordisk mandates office return for all staff, aiming to boost decision-making and business performance amid layoffs.

Novo Nordisk is laying off 9,000 employees, about 11% of its global workforce, as it faces intense competition in the booming ...

Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drug Wegovy and diabetes medicine Ozempic, has ...

Novo Nordisk A/S’s new chief executive officer is calling workers back to the office as the Ozempic maker struggles to catch ...

Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The Danish pharmaceutical company will reduce its 78,400-person workforce by approximately 9,000 positions to streamline ...